3 Tech Stocks With The Big Mo
“These are three top stocks for investors with plenty of risk tolerance to consider for aggressive growth portfolios,” says the author of today’s article of…
What’s To Love About Trading Options?
What’s to love about trading options? Quite a bit! From reducing risk, to providing the flexibility to react to market volatility, to achieving consistent returns…
These Recent Insider Purchases Could Be Strong Signals To Potential Investors
When it comes to insider buying, the author of today’s article notes that “Conventional wisdom says that insiders and 10% owners really only buy shares…
Hijacking The Immune System Creates A Huge Opportunity For These Biotech Stocks
A huge opportunity exists for a group of biotech stocks seeking to “hijack the immune system” with bispecific antibodies. Just what are bispecific antibodies –…
With A Potential Blockbuster Alzheimer’s Drug, Is This Ten-Bagger Stock Still A Buy?
With a potential blockbuster drug in its pipeline that would also be the first new therapy for Alzheimer’s disease in decades, the stock featured in…
Feeling Bullish? These May Be “A Perfect Bet” Right Now For Outsized Returns
If stronger-than-expected fourth-quarter earnings, the prospect of massive government stimulus, and accelerating vaccine distribution has you feeling bullish, a perfect bet right now may be…
5 Penny Stocks With Lots Of Hype – And Red Flags
“The allure of penny stocks lies in their potential to deliver massive gains in a short period of time. But in exchange for that opportunity,…
These Biotech Stocks Could Get “Let Out Of The Cage” This Year
“Few areas in equities are more volatile than small-cap biotech, biopharma and health care. Combined, these sectors produce more massive winners and horrid losers than…
With A Potential Solution To One Of The Biggest COVID Vaccine Problems, Could This Stock Be The Next Moderna?
This previously little-known immunotherapy stock recently saw its shares soar nearly 249% — and its market value surge from $300 million to more than $1…
These Unicorns Are Growing The Fastest, Making Them Potential Future Investments
When it comes to unicorns – privately held startup companies valued at $1 billion or more – the author of today’s article remarks that the…